Qiming U.S. Ventures Management as of Dec. 31, 2023
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 8 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Icosavax | 50.7 | $55M | 3.5M | 15.76 | |
Korro Bio (KRRO) | 16.2 | $18M | 368k | 47.93 | |
Tourmaline Bio (TRML) | 15.4 | $17M | 642k | 26.18 | |
Hillevax (HLVX) | 8.2 | $9.0M | 559k | 16.05 | |
Jasper Therapeutics | 6.2 | $6.7M | 8.5M | 0.79 | |
Ventyx Biosciences (VTYX) | 1.6 | $1.7M | 686k | 2.47 | |
Elevation Oncology (ELEV) | 1.2 | $1.3M | 2.4M | 0.54 | |
Kezar Life Sciences (KZR) | 0.7 | $785k | 829k | 0.95 |